Antiangiogenic therapy for portal hypertension in liver cirrhosis: Current progress and perspectives

about

Antiangiogenic therapy for portal hypertension in liver cirrhosis: Current progress and perspectives

Item

http://www.wikidata.org/entity/Q58760398

description

im September 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Antiangiogenic therapy for por ...... rent progress and perspectives

@en

Antiangiogenic therapy for por ...... rent progress and perspectives

@nl

type

Item

label

Antiangiogenic therapy for por ...... rent progress and perspectives

@en

Antiangiogenic therapy for por ...... rent progress and perspectives

@nl

prefLabel

Antiangiogenic therapy for por ...... rent progress and perspectives

@en

Antiangiogenic therapy for por ...... rent progress and perspectives

@nl

P1476

Antiangiogenic therapy for por ...... rent progress and perspectives

@en

P2093

Dmitry Victorovich Garbuzenko

http://www.w3.org/2001/XMLSchema#string

Evgeniy Leonidovich Kazachkov

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial 4.0 License

P2860

Mechanisms of adaptation of the hepatic vasculature to the deteriorating conditions of blood circulation in liver cirrhosis

New Insight into the Anti-liver Fibrosis Effect of Multitargeted Tyrosine Kinase Inhibitors: From Molecular Target to Clinical Trials

Sorafenib in advanced hepatocellular carcinoma

Angiogenesis: an organizing principle for drug discovery?

Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis.

Intestinal decontamination inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice

Aldosterone enhances ischemia-induced neovascularization through angiotensin II-dependent pathway.

Reversible decrease of portal venous flow in cirrhotic patients: a positive side effect of sorafenib.

Krüppel-like factors: three fingers in many pies.

Anticolon cancer activity of largazole, a marine-derived tunable histone deacetylase inhibitor.

P304

3738-3748

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.3748/WJG.V24.I33.3738

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nikolay Olegovich Arefyev

P5008

ScienceSource

P577

2018-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30197479

http://www.w3.org/2001/XMLSchema#string

P921

P932

6127663

http://www.w3.org/2001/XMLSchema#string